Skip to main content
Log in

Contribution of rs11465788 in IL23R gene to Crohn’s disease susceptibility and phenotype in Chinese population

  • Research Article
  • Published:
Journal of Genetics Aims and scope Submit manuscript

Abstract

Multiple studies have shown that IL23 cytokine plays an essential role in the development of autoimmune diseases by activating IL17-producing helper T (Th17) cells. Given that the susceptibility loci in IL23R for Crohn’s disease (CD) is present in Western population and not in Asian population; we screened the IL23R gene by DNA sequencing to identify susceptibility loci in a selected CD cohort and confirmed it in all our subjects (134 CD and 131 controls). A novel nonsynonymous SNP (p.Gly149Arg, c.445G>A) and 35 single nucleotide polymorphisms (SNPs) were identified. Among them, only rs11465788 was implicated in CD susceptibility (P = 4.9 × 10−4, OR = 0.30). Genotype-phenotypic interaction analysis showed that rs11465788 is associated with nonstricturing and nonpenetrating disease behaviour in CD patients (P = 0.015). Our results provide the evidence that rs11465788 may influence the susceptibility and clinical features of CD in Chinese population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • APDW 2004 Chinese IBDWorking group 2006 Retrospective analysis of 515 cases of Crohn’s disease hospitalization in China: nationwide study from 1990 to 2003. J. Gastroenterol. Hepatol. 21, 1009–1015.

    Google Scholar 

  • Baldassano R. N., Bradfield J. P., Monos D. S., Kim C. E., Glessner J. T., Casalunovo T. et al. 2007 Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn’s disease. Clin. Gastroenterol. Hepatol. l5, 972–976.

    Article  CAS  Google Scholar 

  • Buning C., Schmidt H. H., Molnar T., De Jong D. J., Fiedler T., Buhner S. et al. 2007 Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn’s disease but also ulcerative colitis. Aliment. Pharmacol. Ther. 26, 1025–1033.

    Article  PubMed  CAS  Google Scholar 

  • Cummings J. R., Ahmad T., Geremia A., Beckly J., Cooney R., Hancock L. et al. 2007 Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm. Bowel Dis. 13, 1063–1068.

    Article  PubMed  Google Scholar 

  • Dubinsky M. C., Wang D., Picornell Y., Wrobel I., Katzir L., Quiros A. et al. 2007 IL-23 receptor (IL-23R) gene protects against pediatric Crohn’s disease. Inflamm. Bowel Dis. 13, 511–515.

    Article  PubMed  Google Scholar 

  • Duerr R. H., Taylor K. D., Brant S. R., Rioux J. D., Silverberg M. S., Daly M. J. et al. 2006 A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461–1463.

    Article  PubMed  CAS  Google Scholar 

  • Glas J., Seiderer J., Wetzke M., Konrad A., Torok H. P., Schmechel S. et al. 2007 rs1004819 is the main disease-associated IL23R variant in German Crohn’s disease patients: combined analysis of IL23R, CARD15 and OCTN1/2 variants. PLoS ONE 2, e819.

    Article  PubMed  CAS  Google Scholar 

  • Hue S., Ahern P., Buonocore S., Kullberg M. C., Cua D. J., McKenzie B. S. et al. 2006 Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J. Exp. Med. 203, 2473–2483.

    Article  PubMed  CAS  Google Scholar 

  • Lennard-Jones J. E. 1989 Classification of inflammatory bowel disease. Scand. J. Gastroenterol. Suppl. 170, 2–6; discussion 16–9.

    Article  PubMed  CAS  Google Scholar 

  • Libioulle C., Louis E., Hansoul S., Sandor C., Farnir F., Franchimont D. et al. 2007 Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet. 3, e58.

    Article  PubMed  CAS  Google Scholar 

  • Loftus Jr E. V. 2004 Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126, 1504–1517.

    Article  PubMed  Google Scholar 

  • Loftus Jr E. V. and Sandborn W. J. 2002 Epidemiology of inflammatory bowel disease. Gastroenterol. Clin. North Am. 31, 1–20.

    Article  PubMed  Google Scholar 

  • Mannon P. J., Fuss I. J., Mayer L., Elson C. O., Sandborn W. J., Present D. et al. 2004 Anti-interleukin-12 antibody for active Crohn’s disease. New Engl. J. Med. 351, 2069–2079.

    Article  PubMed  CAS  Google Scholar 

  • McGovern D. and Powrie F. 2007 The IL23 axis plays a key role in the pathogenesis of IBD. Gut 56, 1333–1336.

    Article  PubMed  CAS  Google Scholar 

  • McKenzie B. S., Kastelein R. A. and Cua D. J. 2006 Understanding the IL-23-IL-17 immune pathway. Trend Immunol. 27, 17–23.

    Article  CAS  Google Scholar 

  • Murphy C. A., Langrish C. L., Chen Y., Blumenschein W., Mc-Clanahan T., Kastelein R. A. et al. 2003 Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951–1957.

    Article  PubMed  CAS  Google Scholar 

  • Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J. et al. 2002 A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 168, 5699–5708.

    PubMed  CAS  Google Scholar 

  • Prokunina L. and Alarcon-Riquelme M. E. 2004 Regulatory SNPs in complex diseases: their identification and functional validation. Expert Rev. Mol. Med. 6, 1–15.

    Article  PubMed  Google Scholar 

  • Roberts R. L., Gearry R. B., Hollis-Moffatt J. E., Miller A. L., Reid J., Abkevich V. et al. 2007 IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn’s disease in a study of New Zealand caucasians with inflammatory bowel disease. Am. J. Gastroenterol. 102, 2754–2761.

    Article  PubMed  CAS  Google Scholar 

  • Silverberg M. S., Satsangi J., Ahmad T., Arnott I. D., Bernstein C. N., Brant S. R. et al. 2005 Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a working party of the 2005 montreal world congress of gastroenterology. Can. J. Gastroenterol. 19suppl. A, 5–36.

    PubMed  Google Scholar 

  • Tabor H. K., Risch N. J. and Myers R. M. 2002 Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat. Rev. Genet. 3, 391–397

    Article  PubMed  CAS  Google Scholar 

  • Taylor K. D., Rotter J. I., Taylor K., Yand H. Y. and Rotter J. I. 2007 Inflammatory bowel disease. In Emery and Rimoin’s principles and practice of medical genetics. Churchill Livingstone, London.

    Google Scholar 

  • Tremelling M., Cummings F., Fisher S. A., Mansfield J., Gwilliam R., Keniry A. et al. 2007 IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology 132, 1657–1664.

    Article  PubMed  CAS  Google Scholar 

  • Wang Y. and Ouyang Q. 2007 Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients. J. Gastroenterol. Hepatol. 22, 1450–1455.

    Article  PubMed  Google Scholar 

  • Yamazaki K., Onouchi Y., Takazoe M., Kubo M., Nakamura Y. and Hata A. 2007 Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn’s disease in Japanese patients. J. Hum. Genet. 52, 575–583.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zeng Zhirong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bin, C., Zhirong, Z., Xiaoqin, W. et al. Contribution of rs11465788 in IL23R gene to Crohn’s disease susceptibility and phenotype in Chinese population. J Genet 88, 191–196 (2009). https://doi.org/10.1007/s12041-009-0027-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12041-009-0027-9

Keywords

Navigation